- Home
- / Tetra Bio-Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Tetra Bio-Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2023-11-17
Market Capitalization
$1.7 M
2023-11-17
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|
| Revenue | 112.0K | 1.4M | 5.0K | |
| Cost of goods sold | 67.0K | 951.0K | 5.0K | |
| Gross profit | 4.3M | 480.0K | ||
| Gross profit margin, % | 3812.5% | 33.5% | ||
| Operating expense total | 11.6M | 11.7M | 22.1M | 24.2M |
| Depreciation and amortization | 7.0K | 228.0K | 630.0K | 24.1M |
| EBITDA | (7.4M) | (11.2M) | (22.3M) | (25.8M) |
| EBITDA margin, % | -6564.3% | -781.9% | -446500.0% | |
| EBIT | (7.4M) | (11.4M) | (21.8M) | (49.9M) |
| EBIT margin, % | -6570.5% | -797.8% | -435200.0% | |
| Interest income | 114.0K | 89.0K | 98.0K | 105.0K |
| Interest expense | 1.3M | 1.9M | ||
| Pre tax profit | (7.9M) | (15.3M) | (26.5M) | (52.2M) |
| Net Income | (7.9M) | (15.3M) | (26.5M) | (52.2M) |